Patents by Inventor Stephen Paul Gibson

Stephen Paul Gibson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100035980
    Abstract: The present invention relates to compounds of the formula (I) and pharmaceutically acceptable salts thereof, compositions containing such compounds and the uses of such compounds as antiparasitic agents.
    Type: Application
    Filed: October 15, 2009
    Publication date: February 11, 2010
    Applicant: PFIZER LIMITED
    Inventors: Stephen Paul Gibson, Christelle Lauret
  • Patent number: 7622500
    Abstract: The present invention relates to compounds of the formula (I) and pharmaceutically acceptable salts thereof, compositions containing such compounds and the uses of such compounds as antiparasitic agents.
    Type: Grant
    Filed: February 20, 2008
    Date of Patent: November 24, 2009
    Assignee: Pfizer Limited
    Inventors: Stephen Paul Gibson, Christelle Lauret
  • Publication number: 20080200540
    Abstract: The present invention relates to compounds of the formula (I) and pharmaceutically acceptable salts thereof, compositions containing such compounds and the uses of such compounds as antiparasitic agents.
    Type: Application
    Filed: February 20, 2008
    Publication date: August 21, 2008
    Applicant: PFIZER LIMITED
    Inventors: Stephen Paul Gibson, Christelle Lauret
  • Patent number: 7049444
    Abstract: Compounds of formula (I), their salts and prodrugs thereof, where the substituents are as defined herein are disclosed as opiate binding agents useful in the treatment of opiate-mediated conditions. Also described are processes for making such substances.
    Type: Grant
    Filed: August 7, 2002
    Date of Patent: May 23, 2006
    Assignee: Pfizer Inc.
    Inventors: Bernard Joseph Banks, Robert James Crook, Stephen Paul Gibson, Graham Lunn, Alan John Pettman
  • Patent number: 7012083
    Abstract: There is provided a compound of formula I, wherein R1, R2, R3 and Y have meanings given in the description, which are useful in the prophylaxis and in the treatment of pruritus.
    Type: Grant
    Filed: March 27, 2002
    Date of Patent: March 14, 2006
    Assignee: Pfizer Inc.
    Inventors: Stephen Paul Gibson, Ivan Tommasini, David Morris Gethin, Richard Edward Armer
  • Patent number: 6812236
    Abstract: There is provided a compound of formula I, wherein A, D, R1, R2, R3, X and n have meanings given in the description, which are useful in the prophylaxis and in the treatment of diseases mediated by opiate receptors, such as pruritus.
    Type: Grant
    Filed: March 27, 2002
    Date of Patent: November 2, 2004
    Assignee: Pfizer Inc.
    Inventors: Stephen Paul Gibson, Ivan Tommasini, David Morris Gethin, Richard Edward Armer
  • Patent number: 6750231
    Abstract: There is provided a compound of formula I, wherein Het1, R1, R2, R3, X and n have meanings given in the description, which are useful in the prophylaxis and in the treatment of diseases mediated by opiate receptors, such as pruritus.
    Type: Grant
    Filed: March 19, 2002
    Date of Patent: June 15, 2004
    Assignee: Pfizer Inc
    Inventors: Stephen Paul Gibson, Ivan Tommasini, Kimberley Verrier, Christopher James Dutton, David Morris Gethin, Douglas James Critcher, Richard Edward Armer
  • Publication number: 20030207876
    Abstract: Compounds of formula I, 1
    Type: Application
    Filed: April 8, 2002
    Publication date: November 6, 2003
    Inventors: Bernard Joseph Banks, Douglas James Critcher, Ashley Edward Fenwick, David Morris Gethin, Stephen Paul Gibson
  • Patent number: 6610711
    Abstract: Novel compounds having general formula (I), and pharmaceutically and veterinarily acceptable salts thereof wherein R1, R2, R3, W, Y1, Y2, X, n and y are as defined above and processes for their preparation and intermediate compounds prepared therein. The novel compounds are useful for having utility in the treatment of pruritic dermatoses including allergic dermatitis and atopy in animals and humans.
    Type: Grant
    Filed: May 11, 2000
    Date of Patent: August 26, 2003
    Assignee: Pfizer Inc.
    Inventors: Richard Edward Armer, Christopher James Dutton, David Morris Gethin, Stephen Paul Gibson, Julian Duncan Smith, Ivan Tommasini
  • Publication number: 20030078282
    Abstract: Novel compounds having general formula (I), and pharmaceutically and veterinarily acceptable salts thereof wherein R 1, R 2, R 3, W, Y 1, Y 2, X, n and y are as defined above and processes for their preparation and intermediate compounds prepared therein. The novel compounds are useful for having utility in the treatment.
    Type: Application
    Filed: May 11, 2000
    Publication date: April 24, 2003
    Inventors: Richard Edward Armer, Christopher James Dutton, David Morris Gethin, Stephen Paul Gibson, Julian Duncan Smith, Ivan Tommasini
  • Patent number: 6518282
    Abstract: There is provided a compound of formula I, wherein R1, R2, R3 and R4 have meanings given in the description, which are useful in the prophylaxis and in the treatment of pruritus.
    Type: Grant
    Filed: May 23, 2000
    Date of Patent: February 11, 2003
    Assignee: Pfizer Inc.
    Inventors: Stephen Paul Gibson, Ivan Tommasini
  • Publication number: 20030013875
    Abstract: Compounds of formula (I), their salts and prodrugs thereof, where the substituents are as defined herein are disclosed as opiate binding agents useful in the treatment of opiate-mediated conditions. Also described are processes for making such substances.
    Type: Application
    Filed: August 7, 2002
    Publication date: January 16, 2003
    Applicant: Pfizer, Inc.
    Inventors: Bernard Joseph Banks, Robert James Crook, Stephen Paul Gibson, Graham Lunn, Alan John Pettman
  • Publication number: 20030004340
    Abstract: There is provided a compound of formula I, 1
    Type: Application
    Filed: March 19, 2002
    Publication date: January 2, 2003
    Inventors: Stephen Paul Gibson, Ivan Tommasini, Kimberley Verrier, Christopher James Dutton, David Morris Gethin, Douglas James Critcher, Richard Edward Armer
  • Patent number: 6479516
    Abstract: There is provided a compound of formula I, wherein R1, R2, R3, X and Y have meanings given in the description, which are useful in the prophylaxis and in the treatment of pruritus.
    Type: Grant
    Filed: May 23, 2000
    Date of Patent: November 12, 2002
    Assignee: Pfizer Inc
    Inventors: Stephen Paul Gibson, Ivan Tommasini, Brian Scott Bronk
  • Patent number: 6441000
    Abstract: There is provided a compound of formula I, wherein Het1, T, X, R1, R2 and R3 have meanings given in the description, which are useful in the prophylaxis and in the treatment of diseases mediated by opiate receptors, such as pruritus.
    Type: Grant
    Filed: May 18, 2000
    Date of Patent: August 27, 2002
    Assignee: Pfizer Inc
    Inventors: Stephen Paul Gibson, Ivan Tommasini, Kimberley Verrier, Lee Roberts, Brian Scott Bronk, Richard Edward Armer
  • Publication number: 20020099216
    Abstract: There is provided a compound of formula I, 1
    Type: Application
    Filed: March 27, 2002
    Publication date: July 25, 2002
    Applicant: Pfizer Inc.
    Inventors: Stephen Paul Gibson, Ivan Tommasini, David Morris Gethin, Richard Edward Armer
  • Publication number: 20020099214
    Abstract: There is provided a compound of formula I, 1
    Type: Application
    Filed: March 27, 2002
    Publication date: July 25, 2002
    Applicant: Pfizer Inc.
    Inventors: Stephen Paul Gibson, Ivan Tommasini, David Morris Gethin, Richard Edward Armer
  • Publication number: 20020072616
    Abstract: Compounds of formula (I), their salts and prodrugs thereof, where the substituents are as defined herein are disclosed as opiate binding agents useful in the treatment of opiate-mediated conditions. Also described are processes for making such substances.
    Type: Application
    Filed: October 30, 2001
    Publication date: June 13, 2002
    Applicant: Pfizer Inc.
    Inventors: Bernard Joseph Banks, Robert James Crook, Stephen Paul Gibson, Graham Lunn, Alan John Pettman
  • Publication number: 20020025948
    Abstract: Compounds of formula I, 1
    Type: Application
    Filed: June 18, 2001
    Publication date: February 28, 2002
    Inventors: Bernard Joseph Banks, Douglas James Critcher, Ashley Edward Fenwick, David Morris Gethin, Stephen Paul Gibson
  • Patent number: 6313312
    Abstract: Compounds of formula (I), their salts and prodrugs thereof, where the substituents are as defined herein are disclosed as opiate binding agents useful in the treatment of opiate-mediated conditions. Also described are processes for making such substances.
    Type: Grant
    Filed: December 20, 1999
    Date of Patent: November 6, 2001
    Assignee: Pfizer INC
    Inventors: Bernard Joseph Banks, Robert James Crook, Stephen Paul Gibson, Graham Lunn, Alan John Pettman